StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
4148.TW$31.00+0.33%
Fair $31.00+0.0%

4148.TW

All Cosmos Bio-Tech Holding Corporation

Basic Materials / Agricultural InputsTaiwan

$31.00

+0.10 (+0.33%)

Fairly Valued+0.0%Fair Value $31.00Fund rank 29/100 · Data gapFallback financials|
SA 42/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $209.1M · quality 50.7/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 22/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

42/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific holding-company NAV/SOTP model required: targets are disabled until look-through holdings, debt and discount data exists.
Thesis & Journal · 4148.TWLocal privado en este navegador · All Cosmos Bio-Tech Holding Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.1B

P/E

13.7x

↓

EV/EBITDA

3.8x

↓

ROE

5.6%

↑

Gross Margin

28.1%

↑

Debt/Equity

0.14

↓
52-Week Range$31
$30$47

TradingView lightweight chart

4148.TW price, volumen y niveles de valoración

Último $30.40Periodo -56.3%
Fair value: $31.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-7.3%

FCF CAGR

—

FCF margin

7.1%

FCF / Net income

1.37x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.95B · net income $153.0M · FCF $209.1M

2022-FY → 2025-FY

Gross margin

28.1%-2.6% pts

Operating margin

10.3%-7.5% pts

Net margin

5.2%-4.8% pts

FCF margin

7.1%+7.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.95B$2.95B$2.46B$2.83B$3.70B
Net Income$153.0M$153.0M$128.6M$139.4M$368.2M
EBITDA$378.0M$378.0M$312.8M$310.8M$701.8M
EPS——1.852.035.38
Gross Margin28.1%28.1%27.2%20.8%30.7%
Operating Margin10.3%10.3%6.7%6.6%17.8%
Net Margin5.2%5.2%5.2%4.9%9.9%
Balance Sheet
Debt/Equity0.140.140.100.240.40
Current Ratio4.734.73———
Cash Flow
Free Cash Flow$209.1M$209.1M$-88.1M$795.8M$-17.0M
Returns
ROE5.6%5.6%5.1%6.2%15.6%
Valuation
P/E13.6613.6625.2322.899.68
EV/EBITDA3.823.827.988.154.58
P/B0.760.761.261.531.53
Growth & Yield
Revenue Growth19.9%19.9%-13.0%-23.7%—
EPS Growth——-8.8%-62.3%—
Dividend Yield3.3%3.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -28.4%

Total return

-28.4%

Start / end P/E

n/dx → n/dx

EPS bridge

1.85 → n/d

Residual

-31.7%

EPS growthn/d
Multiple reratingn/d
Dividend+3.3%
Residual / FX / buybacks / cross-term-31.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.